grossman lab banner

Lab News

Adobe PDF

Preoperative dynamic contrast-enhanced MRI correlates with molecular markers of hypoxia and vascularity in specific areas of intratumoral microenvironment and is predictive of patient outcome.
Jensen RL, Mumert ML, Gillespie DL, Kinney AY, Schabel MC, Salzman KL.
Neuro Oncol. 2014 Jan;16(2):280-91.


Adobe PDF

Experimental validation of 5 in-silico predicted glioma biomarkers.
Towner RA, Jensen RL, Vaillant B, Colman H, Saunders D, Giles CB, Wren JD.
Neuro Oncol. 2013 Dec;15(12):1625-34.


Adobe PDF

Differential scanning calorimetry of gliomas: a new tool in brain cancer diagnostics?
Chagovetz AA, Quinn C, Damarse N, Hansen LD, Chagovetz AM, Jensen RL.
Neurosurgery. 2013 Aug;73(2):289-95.


Adobe PDF

Treatment-related brain tumor imaging changes: So-called "pseudoprogression" vs. tumor progression: Review and future research opportunities.
Tran DK, Jensen RL.
Surg Neurol Int. 2013 Apr 17;4(Suppl 3):S129-35.


Adobe PDF

Regression of glioma tumor growth in F98 and U87 rat glioma models by the Nitrone OKN-007.
Towner RA, Gillespie DL, Schwager A, Saunders DG, Smith N, Njoku CE, Krysiak RS 3rd, Larabee C, Iqbal H, Floyd RA, Bourne DW, Abdullah O, Hsu EW, Jensen RL.
Neuro Oncol. 2013 Mar;15(3):330-40.


Adobe PDF

ELTD1, a potential new biomarker for gliomas.
Towner RA, Jensen RL, Colman H, Vaillant B, Smith N, Casteel R, Saunders D, Gillespie DL, Silasi-Mansat R, Lupu F, Giles CB, Wren JD.
Neurosurgery. 2013 Jan;72(1):77-91.